Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OGN Organon & Co

交易中 09-18 13:04:27 EDT

19.90

-0.65

-3.18%

最高20.50	最低19.42	成交量156.24万
今开20.50	昨收20.55	日振幅5.26%
总市值51.23亿	流通市值51.07亿	总股本2.57亿
成交额3,094万	换手率0.61%	流通股本2.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OGN","market":"US","secType":"STK","nameCN":"Organon & Co","latestPrice":19.896,"timestamp":1726679058514,"preClose":20.55,"halted":0,"volume":1562445,"delay":0,"floatShares":256690371,"shares":257473477,"eps":3.87624,"marketStatus":"交易中","marketStatusCode":2,"change":-0.654,"latestTime":"09-18 13:04:27 EDT","open":20.5,"high":20.5,"low":19.42,"amount":30939595.26291,"amplitude":0.052555,"askPrice":19.9,"askSize":393,"bidPrice":19.89,"bidSize":42,"shortable":3,"etf":0,"ttmEps":3.87624,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1726689600000},"adr":0,"adjPreClose":20.55,"dividendRate":0.056293,"preHourTrading":{"tag":"盘前","latestPrice":20.35,"preClose":20.55,"latestTime":"09:21 EDT","volume":3761,"amount":76397.43746500001,"timestamp":1726665699653},"postHourTrading":{"tag":"盘后","latestPrice":20.55,"preClose":20.55,"latestTime":"18:43 EDT","volume":12053,"amount":247690.33,"timestamp":1726612996040},"volumeRatio":2.382533,"impliedVol":0.4271,"impliedVolPercentile":0.2659},"requestUrl":"/m/hq/s/OGN/tweets","defaultTab":"tweets","newsList":[{"id":"2468583567","title":"BUZZ-Roivant因Organon同意以高达12亿美元的价格收购其部门而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2468583567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468583567?lang=zh_cn&edition=full","pubTime":"2024-09-18 20:20","pubTimestamp":1726662022,"startTime":"0","endTime":"0","summary":"    9月18日 - ** Roivant Sciences   股价盘前上涨2.5%至12.35美元** 医疗保健公司Organon   称， ，该公司已同意以12亿美元收购皮肤疗法开发商Dermavant。** 该交易将使 OGN 获得 Dermavant 的银屑病药膏 VTAMA，该药膏于 2022 年 5 月获得美国 FDA 批准。** 作为交易的一部分，OGN 将支付 1.75 亿美元的预付款以及高达 9.5 亿美元的里程碑付款** OGN 预计在今年第四季度完成交易** 截至上次收盘，ROIV 股价年累计上涨 7.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065171311.SGD","ROIV","LU2065170008.USD","BK4588","LU2065171402.SGD","BK4585","BK4559","BK4007","LU2065169927.USD","OGN"],"gpt_icon":0},{"id":"2468300195","title":"更新版 1-Organon 拟以高达 12 亿美元的价格收购皮肤疗法开发商 Dermavant","url":"https://stock-news.laohu8.com/highlight/detail?id=2468300195","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468300195?lang=zh_cn&edition=full","pubTime":"2024-09-18 19:55","pubTimestamp":1726660516,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (第 2-4 段增加了交易细节)    路透9月18日 - 医疗保健公司Organon   周三表示，已同意以不超过12亿美元的价格收购Roivant   旗下皮肤疗法开发商Dermavant。Organon公司将支付1.75亿美元的预付款，以及7500万美元的里程碑付款，在达到某些商业里程碑时最高支付9.5亿美元。Dermavant 的 VTAMA 银屑病膏于 2022 年 5 月获得美国食品和药物管理局批准。银屑病是一种常见的慢性炎症性皮肤病。公司预计将在今年第四季度完成交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN","LU2065169927.USD","BK4588","LU2065171402.SGD","BK4559","BK4585","BK4139","ROIV","BK4007","LU2065170008.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2468307175","title":"Organon 将以高达 12 亿美元的价格收购疗法开发商 Dermavant","url":"https://stock-news.laohu8.com/highlight/detail?id=2468307175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468307175?lang=zh_cn&edition=full","pubTime":"2024-09-18 19:37","pubTimestamp":1726659434,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月18日 - 医疗保健公司Organon   周三表示，已同意以不超过12亿美元的价格收购Roivant   旗下的Dermavant公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ROIV","BK4007","LU2065169927.USD","BK4139","OGN","BK4585","LU2065171311.SGD","LU2065171402.SGD","LU2065170008.USD","BK4559"],"gpt_icon":0},{"id":"2467771699","title":"\"欧翎先锋\"卓越药师峰会盛大召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2467771699","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467771699?lang=zh_cn&edition=full","pubTime":"2024-09-13 15:02","pubTimestamp":1726210920,"startTime":"0","endTime":"0","summary":"弘扬药师专业风采，打造药店精细化慢病管理\"新名片\" 上海2024年9月13日 /美通社/ -- 今日，2024年第二届\"欧翎先锋\"卓越药师峰会圆满落幕。本届峰会上，由新华网主办，国际药学联合会、欧加隆共同参与的\"欧翎先锋我们身边了不起的医药零售人\"全国优秀零售药师事迹展，在各方的见证下，揭晓了首批优秀药师代表，并启动了新一轮优秀药师事迹的征集。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4505824_ZH05824_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4588","LU2065170008.USD","BK4007","LU2065171311.SGD","OGN","BK4559","LU2065169927.USD","BK4585","LU2065171402.SGD"],"gpt_icon":0},{"id":"2460989001","title":"礼来(LLY.US)与Organon(OGN.US)扩大偏头痛药物Emgality商业化协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2460989001","media":"智通财经网","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460989001?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:27","pubTimestamp":1724160456,"startTime":"0","endTime":"0","summary":"礼来与Organon已将偏头痛药物Emgality(galcanezumab)的商业化协议扩展至另外11个市场。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20240820/20240820212825_14995.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240820/20240820212825_14995.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1167292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0471298694.HKD","LU1069344957.HKD","LU0122379950.USD","LU0006306889.USD","LU1057294990.SGD","LU2065170008.USD","GB00BDT5M118.USD","IE0002141913.USD","LU0689472784.USD","LU0882574139.USD","LU1551013342.USD","LU0079474960.USD","BK4559","LU0385154629.USD","LU0882574055.USD","IE00BJT1NW94.SGD","LU1623119135.USD","LU0198837287.USD","LU0823416689.USD","LU0109391861.USD","LU1064131342.USD","LU0061475181.USD","LU0708995401.HKD","LU0094547139.USD","LU1551013425.SGD","LU2065171311.SGD","IE00BJJMRZ35.SGD","BK4585","LU0058720904.USD","IE0004445239.USD","BK4516","LU1280957306.USD","LLY","IE00BFTCPJ56.SGD","LU0466842654.USD","LU0256863811.USD","BK4588","LU0114720955.EUR","BK4007","LU1061106388.HKD","LU1035775433.USD","IE0009355771.USD","LU0096364046.USD","LU0097036916.USD","LU0820561909.HKD","OGN","IE00BJLML261.HKD","LU0943347566.SGD","IE00B1BXHZ80.USD","LU0820561818.USD"],"gpt_icon":1},{"id":"2458469739","title":"Organon & Co.2024财年第二财季实现净利润1.95亿美元，同比减少19.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458469739","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458469739?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:14","pubTimestamp":1723392890,"startTime":"0","endTime":"0","summary":"8月12日，Organon & Co.公布财报，公告显示公司2024财年第二财季净利润为1.95亿美元，同比减少19.42%；其中营业收入为16.07亿美元，同比减少0.06%，每股基本收益为0.76美元。从资产负债表来看，Organon & Co.总负债120.10亿美元，其中短期债务9.00百万美元，资产负债比为1.02，流动比率为1.64。机构评级：截至2024年8月12日，当前有8家机构对Organon & Co.目标价做出预测，其中目标均价为22.50美元，其中最低目标价为17.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812001452959044ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812001452959044ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN"],"gpt_icon":0},{"id":"2457422468","title":"Organon & Co.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457422468","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457422468?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:57","pubTimestamp":1723039058,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时57分，Organon & Co.股票出现异动，股价急速上涨5.04%。截至发稿，该股报19.59美元/股，成交量27.7894万股，换手率0.11%，振幅3.54%。Organon & Co.股票所在的制药行业中，整体跌幅为0.50%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807215739941ff0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807215739941ff0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065169927.USD","LU2065171402.SGD","BK4585","BK4588","BK4007","OGN","LU2065171311.SGD","BK4559","LU2065170008.USD"],"gpt_icon":0},{"id":"2457732550","title":"BUZZ--美国股票走势-Lumen Technologies、Broadridge Financial、IDEXX","url":"https://stock-news.laohu8.com/highlight/detail?id=2457732550","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457732550?lang=zh_cn&edition=full","pubTime":"2024-08-07 00:30","pubTimestamp":1722961818,"startTime":"0","endTime":"0","summary":"美东时间12:14，道琼斯工业平均指数  上涨1.22%，报39,175.66点。标普500指数  上涨1.74%，报5276.66点；纳斯达克综合指数  上涨1.81%，报16492.856点。** CVS Health Corp   ：下跌 0.5%BUZZ - 巴克莱认为，成本上升趋势对 CVS 第二季度和全年利润构成风险   ** Jacobs Solutions Inc   ：上涨 1.2%BUZZ - 在第三季度收入超预期后上涨   ** IDEXX Laboratories Inc   ：上涨 4.3%BUZZ - 在预期下调并不像人们担心的那样糟糕之后，在缓解性反弹中上涨   标准普尔 500 指数的 11 个主要行业：通信服务","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","PSQ","EXPD",".SPX","BR","NQmain","IDXX","QID","CSX","TAP","SDOW","TALK","ELEV","HIMS","BUZZ","MPC","ZTS","CVS","J","BAX",".IXIC","ZI","GEHC","SQQQ","FIS","VNO","SRPT","MNQmain","DXD","BVS",".DJI","BMRN","OGN","UDOW","CAT","SPWR","TDG","DJX","KVUE","MCK","MKTX","LUMN","DDM","HSIC"],"gpt_icon":1},{"id":"2457023094","title":"BUZZ-Organon & Co 因下调财年销售预期而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023094","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023094?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:01","pubTimestamp":1722952888,"startTime":"0","endTime":"0","summary":"    8月6日 - ** 专注于女性健康的 Organon    股价下跌 9%，报 18.31 美元** 公司目前预计全年收入在62.5亿至64.5亿美元之间，而之前的预期为62亿至65亿美元。** Organon 公布第二季度收入为 16.1 亿美元，预计为 16.3 亿美元。** 公司妇女保健产品的销售额增长 3%，达到 4.49 亿美元，与预期一致 ** Organon 既有品牌部门和生物仿制药业务的收入低于预期** 截至上一交易日收盘，股价累计上涨 40","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BUZZ","LU2065170008.USD","BK4588","LU2065171402.SGD","BK4585","BK4559","BK4007","LU2065169927.USD","OGN"],"gpt_icon":0},{"id":"1152349908","title":"异动解读 | Organon & Co二季度业绩不佳 股价盘中大跌7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152349908","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152349908?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:43","pubTimestamp":1722951811,"startTime":"0","endTime":"0","summary":"制药公司Organon & Co今日公布了2024年第二季度财报,业绩数据令人失望,导致其股价盘中大跌7.38%。\n\n财报显示,Organon & Co本季度调整后每股收益为1.12美元,低于去年同期的1.31美元。营业收入为16.1亿美元,同比下降0.1%,也未能达到分析师预期的16.3亿美元。公司本季度净收入为1.95亿美元,较上年同期有所下降。\n\n值得注意的是,在过去三个月里,分析师对Organon & Co的平均盈利预期下调了约6.3%,显示出对公司未来前景的担忧。目前分析师对该公司股票的平均评级为\"持有\"。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"gpt_icon":0},{"id":"2457400330","title":"Organon & Co 公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457400330","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457400330?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:32","pubTimestamp":1722951178,"startTime":"0","endTime":"0","summary":"   * Organon & Co   公布的截至6月底的季度调整后每股收益为1.12美元，低于去年同期的每股收益1.31美元。八位分析师对该季度的平均预期为每股收益 1.08 美元。华尔街预期为每股收益 93 美分至 1.24 美元。* Organon & Co 公司公布的本季度每股收益为 75 美分。* 公司报告的季度净收入为 1.95 亿美元。* Organon & Co 的股价本季度下跌了 2.5%，今年迄今为止上涨了 40.0%。华尔街对 Organon & Co 的 12 个月目标价中位数为 22.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Organon & Co 公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4007","LU2065171402.SGD","OGN","LU2065169927.USD","LU2065171311.SGD","BK4559","LU2065170008.USD"],"gpt_icon":0},{"id":"2457028730","title":"Organon & Co.盘中异动 大幅下跌5.40%报19.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457028730","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457028730?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:32","pubTimestamp":1722951141,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时32分，Organon & Co.股票出现异动，股价快速下跌5.40%。截至发稿，该股报19.10美元/股，成交量8.1822万股，换手率0.03%，振幅3.37%。Organon & Co.股票所在的制药行业中，整体涨幅为0.90%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213221aefd8581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213221aefd8581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","LU2065169927.USD","OGN","BK4559","BK4585","BK4007","LU2065170008.USD","LU2065171402.SGD","BK4588"],"gpt_icon":0},{"id":"2456237521","title":"Organon & Co   预计每股收益1.08美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456237521","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456237521?lang=zh_cn&edition=full","pubTime":"2024-08-03 00:44","pubTimestamp":1722617062,"startTime":"0","endTime":"0","summary":"   * Organon & Co    将于8月6日公布截至2024年6月30日的财报，预计季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于新泽西州泽西城的公司的营收将从去年同期的16.1亿美元增至16.31亿美元，增幅为1.4%。* LSEG 的分析师平均预期 Organon & Co 每股收益为 1.08 美元。* 华尔街对 Organon & Co 的 12 个月目标价中值为 22.00 美元，高于其上一次收盘价 21.65 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Organon & Co   预计每股收益1.08美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"gpt_icon":0},{"id":"2456153236","title":"Organon & Co.盘中异动 早盘快速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456153236","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456153236?lang=zh_cn&edition=full","pubTime":"2024-08-02 23:21","pubTimestamp":1722612118,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日23时21分，Organon & Co.股票出现波动，股价急速下跌5.01%。截至发稿，该股报20.57美元/股，成交量43.2609万股，换手率0.17%，振幅4.30%。Organon & Co.股票所在的制药行业中，整体跌幅为2.21%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802232158aefcfc5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802232158aefcfc5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU2065171402.SGD","LU2065170008.USD","OGN","BK4559","BK4585","LU2065171311.SGD","LU2065169927.USD","BK4588"],"gpt_icon":0},{"id":"2450391818","title":"Organon & Co.盘中异动 快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450391818","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450391818?lang=zh_cn&edition=full","pubTime":"2024-07-12 02:07","pubTimestamp":1720721246,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日02时07分，Organon & Co.股票出现波动，股价大幅拉升5.07%。截至发稿，该股报20.93美元/股，成交量87.1328万股，换手率0.34%，振幅3.92%。Organon & Co.股票所在的制药行业中，整体跌幅为0.30%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712020726941f657a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712020726941f657a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","OGN","LU2065171402.SGD","BK4559","BK4588","BK4585"],"gpt_icon":0},{"id":"2437087237","title":"复宏汉霖与Organon合作取得新进展 第6款申报上市产品HLX14获欧洲药品管理局受理今日，复宏汉霖(2696.HK)与Organon(NYSE: OGN)共同宣布，在研地舒单抗(Prolia®/Xgeva®)生物类似药HLX14的上市许可申请(MAA)获欧洲药品管理局(EMA)受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2437087237","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437087237?lang=zh_cn&edition=full","pubTime":"2024-05-24 19:03","pubTimestamp":1716548614,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NYSE","LU2065171311.SGD","LU2065170008.USD","02696","MAA","BK4588","BK4215","LU2065171402.SGD","BK4585","BK4559","BK4007","BK1161","LU2065169927.USD","OGN"],"gpt_icon":0},{"id":"2434589869","title":"Organon & Co.2024财年第一财季实现净利润2.01亿美元，同比增加13.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434589869","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434589869?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:21","pubTimestamp":1715358069,"startTime":"0","endTime":"0","summary":"3月31日，Organon & Co.公布财报，公告显示公司2024财年第一财季净利润为2.01亿美元，同比增加13.56%；其中营业收入为16.22亿美元，同比增加5.46%，每股基本收益为0.79美元。从资产负债表来看，Organon & Co.总负债118.43亿美元，其中短期债务9.00百万美元，资产负债比为1.01，流动比率为1.65。机构评级：截至2024年3月31日，当前有8家机构对Organon & Co.目标价做出预测，其中目标均价为22.50美元，其中最低目标价为16.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110021178af1a93f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110021178af1a93f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN"],"gpt_icon":0},{"id":"2432601098","title":"Organon & Co.盘中异动 早盘急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432601098","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432601098?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:32","pubTimestamp":1714656728,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时32分，Organon & Co.股票出现波动，股价急速上涨5.36%。截至发稿，该股报19.84美元/股，成交量10.9102万股，换手率0.04%，振幅2.18%。Organon & Co.股票所在的制药行业中，整体涨幅为0.16%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502213209861eaae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502213209861eaae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN","LU2065169927.USD","BK4588","LU2065171402.SGD","BK4559","BK4585","BK4007","LU2065170008.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2432087053","title":"Organon & Co    预计每股收益 93 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432087053","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432087053?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:52","pubTimestamp":1714495966,"startTime":"0","endTime":"0","summary":"   * Organon & Co    将于5月2日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于新泽西州泽西城的公司的营收将从去年同期的15.4亿美元增至15.63亿美元，增幅为1.6%。* LSEG 分析师对 Organon & Co 的平均预期为每股收益 93 美分。* 华尔街对 Organon & Co 的 12 个月目标价中位数为 21.00 美元，高于其上次收盘价 18.90 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"gpt_icon":0},{"id":"2428390560","title":"全国零售药店\"疼痛关爱中心\"建设全面启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2428390560","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428390560?lang=zh_cn&edition=full","pubTime":"2024-04-17 17:48","pubTimestamp":1713347280,"startTime":"0","endTime":"0","summary":"世界痛风日到来之际，由中国健康促进与教育协会主办、欧加隆共同参与的零售药店\"疼痛关爱中心\"建设全国启动会在浙江杭州成功举办。大会的召开，代表着中国健康促进与教育协会发起的\"助力健康中国，关注疼痛疾病管理药师赋能项目\"在2024年的稳步深耕。今天，欧加隆非常荣幸携手主办协会，共同建设一张覆盖全国的零售药店'疼痛关爱中心'专业网络，构建疼痛管理从院内到院外的'全景诊疗'闭环。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4390128_ZH90128_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2065171311.SGD","LU2065169927.USD","OGN","BK4559","BK4585","BK4007","LU2065170008.USD","LU2065171402.SGD","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.organon.com","stockEarnings":[{"period":"1week","weight":0.0229},{"period":"1month","weight":0.0098},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.123},{"period":"1year","weight":0.056},{"period":"ytd","weight":0.4251}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Organon & Co.是一家特拉华州公司，成立于2020年3月11日。Organon是一家基于科学的全球制药公司，通过一系列针对女性健康，生物仿制药和知名品牌的处方疗法，开发并提供创新的健康解决方案。他们的使命是成为世界领先的女性保健公司，每天为每个女性提供更好，更健康的服务。他们计划利用自身在生殖健康方面的优势，建立一系列健康解决方案，为从青春期到更年期及以后的妇女提供服务。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.093787},{"month":2,"riseRate":0.666667,"avgChangeRate":0.009437},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.00802},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.012449},{"month":5,"riseRate":0.666667,"avgChangeRate":0.03585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.022403},{"month":7,"riseRate":0.5,"avgChangeRate":0.002701},{"month":8,"riseRate":0.5,"avgChangeRate":0.022289},{"month":9,"riseRate":0,"avgChangeRate":-0.12557},{"month":10,"riseRate":0.666667,"avgChangeRate":0.03051},{"month":11,"riseRate":0,"avgChangeRate":-0.148452},{"month":12,"riseRate":1,"avgChangeRate":0.129665}],"exchange":"NYSE","name":"Organon & Co","nameEN":"Organon & Co"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Organon & Co,OGN,Organon & Co股票,Organon & Co股票老虎,Organon & Co股票老虎国际,Organon & Co行情,Organon & Co股票行情,Organon & Co股价,Organon & Co股市,Organon & Co股票价格,Organon & Co股票交易,Organon & Co股票购买,Organon & Co股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况